PhotoMedex, Inc. (NASDAQCM:PHMD) is an interesting player in the Healthcare space, with a focus on Medical Appliances & Equipment. The stock has been active on the tape, currently trading at $2.42, up from yesterday’s close by 16.35%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.
Does this stock stack up well when compared to its peers in the space? Let’s take a look. PhotoMedex, Inc. (PHMD) currently trades with a market capitalization of $10.69M. That value represents a market adjusting for revenues that have been falling by -59.70% on a quarterly year/year basis as of the company’s last quarterly report.
The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For PHMD, the company currently has $1.29M of cash on the books, which is offset by $161.00k current liabilities. You can get a sense of how sustainable that is by a levered free cash flow of $3.69M over the past twelve months. Generally speaking, earnings are expected to fall in coming quarters. Analysts are forecasting earnings of 0.55 on a per share basis this quarter.
No analysis is ever complete without a thorough survey of a stock’s technical behavior. Looking at the stock’s movement on the chart, PhotoMedex, Inc. recorded a 52-week high of 5.60. It is now trading 3.52 off that level. The stock is trading 2.73 its 50-day moving average by 0.65. The stock carved out a 52-week low down at 0.90.
In recent action, PhotoMedex, Inc. (PHMD) has made a move of -14.18% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is outperforming the S&P 500 by 0.09, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 2.38M with 2.51% sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of PHMD.